Blauvelt, A., Leonardi, C., Elewski, B., Crowley, J., Guenther, L., Gooderham, M., Langley, R., Vender, R., Pinter, A., Griffiths, C., Tada, Y., Elmaraghy, H., Lima, R., Gallo, G., Renda, L., Burge, R., Park, S., Zhu, B., Papp, K., & , (2021). a head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial. British journal of dermatology, 184, 1047–1058. http://access.bl.uk/ark:/81055/vdc_100132239808.0x000055